592 POSTER Obatoclax (GX17–070), a small molecule pan-bcl-2 inhibitor, in combination with docetaxel in a phase I/II trial enrolling patients with relapsed non-small cell lung cancer (NSCLC)
Year: 2008
Type: conference-abstract
Authors: A. Chiappori, C. Williams, D. Northfelt, J. Adams, S. Malik, M. Edelman, P. Rosen, D. Van Echo, M. Berger, E. Haura
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2073475364